Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-Immune Adults: A Phase 1, Double-Blinded Placebo Controlled Dosage Escalation Study.
Saved in:
| Title: | Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-Immune Adults: A Phase 1, Double-Blinded Placebo Controlled Dosage Escalation Study. |
|---|---|
| Authors: | Koram, Kwadwo A.1 KKoram@noguchi.ug.edu.gh, Adu, Bright2, Ocran, Josephine1, Karikari, Yaa S.1, Adu-Amankwah, Susan1, Ntiri, Michael1, Abuaku, Benjamin1, Dodoo, Daniel2, Gyan, Ben2, Kronmann, Karl C.1,3, Nkrumah, Francis1 |
| Source: | PLoS ONE. 9/19/2016, Vol. 11 Issue 9, p1-18. 18p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
